93 related articles for article (PubMed ID: 6420598)
1. Second primary cancers following treatment of Hodgkin's disease.
Boivin JF; Hutchison GB; Lyden M; Godbold J; Chorosh J; Schottenfeld D
J Natl Cancer Inst; 1984 Feb; 72(2):233-41. PubMed ID: 6420598
[TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
3. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease.
Henry-Amar M
NCI Monogr; 1988; (6):65-72. PubMed ID: 3352791
[TBL] [Abstract][Full Text] [Related]
4. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
Henry-Amar M
J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
[TBL] [Abstract][Full Text] [Related]
5. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
7. Risk of second cancers after treatment for Hodgkin's disease.
Tucker MA; Coleman CN; Cox RS; Varghese A; Rosenberg SA
N Engl J Med; 1988 Jan; 318(2):76-81. PubMed ID: 3336397
[TBL] [Abstract][Full Text] [Related]
8. [Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
Glanzmann C; Stahel R
Praxis (Bern 1994); 1995 Oct; 84(41):1140-7. PubMed ID: 7481323
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P
Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
[TBL] [Abstract][Full Text] [Related]
10. Second neoplasms in Hodgkin's disease: current controversies.
Zarrabi MH; Rosner F
Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
[TBL] [Abstract][Full Text] [Related]
11. [Hodgkin's lymphoma and secondary leukemias].
Centurioni R; Brianzoni MF; Salvi A; Montillo M; Rupoli S; Olivieri A; Leoni P; Danieli G
Recenti Prog Med; 1993 May; 84(5):328-35. PubMed ID: 8511392
[TBL] [Abstract][Full Text] [Related]
12. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
13. [Second neoplasms in Hodgkin's disease].
Cebreiros I; Ordóñez A; García de Paredes ML; Vicente J; Martín G; González Barón M
Rev Clin Esp; 1989 Mar; 184(5):247-8. PubMed ID: 2772295
[TBL] [Abstract][Full Text] [Related]
14. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
15. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
16. Long-term cause-specific mortality of patients treated for Hodgkin's disease.
Aleman BM; van den Belt-Dusebout AW; Klokman WJ; Van't Veer MB; Bartelink H; van Leeuwen FE
J Clin Oncol; 2003 Sep; 21(18):3431-9. PubMed ID: 12885835
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
[TBL] [Abstract][Full Text] [Related]
18. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
19. Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.
Storm HH; Prener A
Natl Cancer Inst Monogr; 1985 Dec; 68():389-409. PubMed ID: 4088311
[TBL] [Abstract][Full Text] [Related]
20. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
N Engl J Med; 1987 Sep; 317(11):707-9. PubMed ID: 3627177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
